Simon Douglas, PhD

Simon, 65, was appointed Non-executive Chairman in September 2011, having previously been CEO. He has over 35 years’ experience in the biotech industry, including ten years working for Amersham International (now GE), ICI and Zeneca (now Astra Zeneca) in a variety of commercial and technical positions and over five years with Tepnel Life Sciences plc (now Hologic Inc), a London Stock Exchange listed diagnostic company where he was Chief Executive. He has been the CEO/Executive Chairman of three other venture capital-backed Life Science companies (DRI Ltd, Lab901 Ltd and Biofortuna Ltd) and headed up the trade sale of two of these as well as was the Chairman of Cambridge Nutritional Sciences plc, an AIM listed Healthcare company. He is currently the Non-executive Chairman of Abselion Ltd and Chairman of C-Major Medical Ltd, two venture capital-backed companies. Simon is not considered to be independent, as he formerly held the position of CEO.